ACTUAL PROBLEMS OF RAW MATERIALS CHEMICAL STANDARDIZATION OF MEDICINAL PLANTS OF THE GENUS HAWTHORN ΈCRATAEGUS L.Ή


Cite item

Full Text

Abstract

The plants of the genus Hawthorn (Crataegus L.) are shrubs or small trees that have been used in medicine since ancient times. Nowadays, on the basis of raw hawthorn, the preparations are available for treatment and prevention of heart failure. The aim of the work is to analyze and systematize research results in the fi eld of chemical standardization of hawthorn raw materials in pharmacopoeias of various countries. Materials and methods. The study was conducted with the use of the State Pharmacopoeia of the USSR, XI-th edition, the State Pharmacopoeia of the Russian Federation, XIII-th edition, the European Pharmacopoeia, 6-th edition, the United States Pharmacopeia, 32-nd editions, the State Pharmacopoeia of the Republic of Belarus and the Republic of Kazakhstan, as well as the information and search (PubMed) and library databases (eLibrary). Results and discussion. In this review, the results of research in the fi eld of chemical standardization of hawthorn raw materials in pharmacopoeias of various countries are systematized. It is determined that in the methods of analysis of raw materials of the species of the genus Hawthorn (Crataegus L.), included in domestic and foreign Pharmacopoeias, various methodological and methodological approaches to the standardization of fruits, fl owers and leaves are used. Besides, it has been found out that the raw materials of the same name are analyzed using different techniques. In our opinion, the use of various extractants in the methods is not always justifi ed from the point of view of the physical-chemical and spectral characteristics of the substances being analyzed. It is also shown that in the methods of qualitative and quantitative analysis of active substances (fl avonoids, procyanidins), the orientation to diagnostically signifi cant standard substances is not always conducted. Conclusion. The analysis of existing methods of qualitative analysis (the section of authenticity) and quantitative determination of the target substances indicates the necessity to unify the methods of raw materials analysis and preparations of hawthorn species on the basis of scientifi cally based approaches to standardization. 

About the authors

T. V. Morozova

Federal State Budget Educational Institution of Higher Education “Samara State Medical University”

Email: tanyfrost@mail.ru

V. A. Kurkin

Federal State Budget Educational Institution of Higher Education “Samara State Medical University”

Email: Kurkinvladimir@yandex.ru

O. E. Pravdivtseva

Federal State Budget Educational Institution of Higher Education “Samara State Medical University”

Email: pravdivtheva@mail.ru

References

  1. Martins Ekor. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety // Frontiers in Pharmacology. 2013. No 4. P. 177. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887317/ (дата обращения: 24.01.2018). doi: 10.3389/fphar.2013.00177
  2. Pal S.K., Shukla Y. Herbal medicine: current status and the future // Asian Pacifi c Journal of Cancer Prevention. 2003. No 4(4). P. 281-288. URL: https://www.ncbi.nlm.nih.gov/pubmed/14728584 (дата обращения: 24.01.2018)
  3. Самбукова Т.В., Овчинников Б.В., Ганапольский В.П., Ятманов А.Н., Шабанов П.Д. Перспективы использования фитопрепаратов в современной фармакологии // Обзоры по клинической фармакологии и лекарственной терапии. 2017. Т. 15. № 2. С. 56–63. doi: 10.17816/RCF15256-63
  4. World Health Organization. Cardiovascular diseases (CVDs) URL: http://www.who.int/mediacentre/factsheets/fs317/en/ (дата обращения: 24.01.2018)
  5. Басырова И.Р., Либис Р.А. Распространенность основных факторов риска сердечно-сосудистых заболеваний и их комбинаций у жителей города Оренбурга // Аспирантский вестник Поволжья. 2017. № 1–2. С. 48–53.
  6. Самылина И.А., Сорокина А.А., Пятигорская Н.В. Боярышник (Crataegus): возможности медицинского применения // Фарматека. 2010. № 8. С. 83–85.
  7. Rastogi S., Pandey M.M., Rawat A.K. Traditional herbs: a remedy for cardiovascular disorders // Phytomedicine. 2016. No 23(11). P. 1082–1089. URL: https://www.ncbi.nlm.nih.gov/pubmed/26656228 (дата обращения: 24.01.2018). doi: 10.1016/j.phymed.2015.10.012
  8. Zorniak M., Szydlo B., Krzeminski T.F. Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences // Journal of physiology and pharmacology. 2017. No 68 (4). P. 521–526. URL: https:// www.ncbi.nlm.nih.gov/pubmed/29151068 (дата обращения: 24.01.2018)
  9. JieWang, Xingjiang Xiong, Bo Feng. Effect of Crataegus Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach // Evidence-Based Complementary and Alternative Medicine. 2013. Available at: https:// www.hindawi.com/journals/ecam/2013/149363/ (дата обращения: 24.01.2018). doi: 10.1155/2013/149363
  10. Liu X.Y., Zhou L., Liang R.Y. Study on lipid regulation mechanism of total fl avonoids from folium Crataegi by 3T3-L1 cells // Chin. Arch. Tradit. Chin. Med. 2009. No. 27. P. 1066–1068.
  11. Yang R.M., Chen H.M., Gao N.N., Song X., Li J.L., Cai D.Y. Mechanism of early atherosclerosis in guinea pig: abnormal metabolism of LDL-C // Acta Lab. Anim. Sci. Sin. 2011. Vol. 23. P. 237–241.
  12. Yang X.P. Medicinal value of Crataegus pinnatifi da // Jilin Med. J. 1998. Vol. 19. P. 41.
  13. Yuan Y., Zhao J., Gao H.J., Wa ng J.H. Experimental study on effect of hawthorn on compounding hypertension and hyperlipoidemia rats // J. Xinjiang Med. Univ. 2013. Vol. 35. P. 52–27.
  14. Li C.Q., Wu W., Tong Y. Study on germicidal efficacy of extract of hawthorn fruit pit and its influencing factors // Chin. J. Disinfect. 2007. Vol. 24. P. 50–52.
  15. Lin L., Chen Y.J., Li L., Cao Y., Sun Q.X. Experimental observation on germicidal efficacy of hawthorn liquid and its influencing factors // Chin. J. Disinfect. 2000. Vol. 17. P. 85–88.
  16. Li L., Lv H., Pang H. Anti-aging effect of total flavone of hawthorn leaf // Lishizhen Med. Mater. Med. Res. 2007. Vol. 9. P. 2143–2144.
  17. Ji Y.S., Li H., Yang S.J. Protective effect and its molecular mechanism of FMCL on PC 12 cells apoptosis induced by H2O2 // Chin. Pharmacol. Bull. 2006. Vol. 22. P. 760–762.
  18. Chen Z.Y., Yan M.X., He B.H. The Change and the immpact of IFHL on oxidative stress in the formation of NASH in rats // J. Med. Res. 2007. Vol. 36. P. 33–36.
  19. Wang C.L., Lu B.Z., Hou G.L. Chemical constituent, pharmacological effects and clinical application of Crataegus pinnatifi da // Strait Pharm. J. 2010. Vol. 3. P. 75–78.
  20. Pittler M.H., Schmidt K., Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of random-ized trials // American Journal of Medicine. 2003. No. 114(8). P. 665–674. URL: https://www.ncbi.nlm.nih.gov/pubmed/12798455 (дата обращения: 24.01.2018)
  21. Hu M., Zeng W., Tomlinson B. Evaluation of a crataegus-based multiherb formula for dyslipidemia: a random-ized, double-blind, placebo-controlled clinical trial // Evidence-Based Complementary and Alternative Medicine. 2014. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009229/ (дата обращения: 24.01.2018). doi: 10.1155/2014/365742
  22. Jalaly L., Sharifi G., Faramarzi M., Nematollahi A., Rafi eian-kopaei M., Amiri M., Moattar F. Comparison of the effects of Crataegus oxyacantha extract, aerobic exercise and their combination on the serum levels of ICAM-1 and E-Selectin in patients with stable angina pectoris // DARU Journal of Pharmaceutical Sciences. 2015. No. 23. P. 54. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684934/ (дата обращения: 24.01.2018). doi: 10.1186/s40199-015-0137-2
  23. Mustapha N., Pinon A., Limami Y., Simon A., Ghedira K., Hennebelle T., Chekir-Ghedira L. Crataegus azarolus Leaves Induce Antiproliferative Activity, Cell Cycle Arrest, and Apoptosis in Human HT-29 and HCT-116 Colorectal Cancer Cells // Journal of Cellular Biochemistry. 2016. No 117(5). P. 1262–1272. URL: https://www. ncbi.nlm.nih.gov/pubmed/26495895 (дата обращения: 24.01.2018). doi: 10.1002/jcb.25416
  24. Государственная фармакопея СССР. 11-е издание. Вып. 2. М.: Медицина, 1990. 400 с.
  25. Куркин В.А., Морозова Т.В., Правдивцева О.Е. Исследование по разработке методики стандартизации листьев боярышника кроваво-красного // Химия растительного сырья. 2017. № 3. С 169–173.
  26. European Pharmacopoeia. 8 ed. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe, 2013.
  27. United States Pharmacopeia. URL: http://www.uspbpep.com/usp32/pub/data/v32270/usp32nf27s0_m36580. html
  28. Государственная фармакопея Республики Беларусь. 1-е издание. Том 2. Министерство здравоохранения Республики Беларусь: Минск, 2007. 471 с.
  29. Атлас ареалов и ресурсов лекарственных растений СССР. М.: ГУГК, 1980. С. 242–243.
  30. Силаева Т.Б., Агеева А.М., Кирюхин И.В., Матвиенко И.И. О боярышниках (Crataegus L.) в Республике Мордовия // Фиторазнообразие Восточной Европы. 2007. №4. С. 216–218.
  31. Государственная Фармакопея Российской Федерации. XIII издание. Т. 1. М., 2015. 1470 с.
  32. Государственная Фармакопея Российской Федерации. XIII издание. Т. 2. М., 2015. 1004 с.
  33. Государственная Фармакопея Российской Федерации. XIII издание. Т. 3. М., 2015. 1294 с.
  34. Государственная фармакопея Республики Казахстан. 1-е издание. Том 2. Министерство здравоохранения Республики Казахстан: Астана, 2009. 803 с.
  35. Куркин В.А., Куркина А.В., Правдивцева О.Е., Морозова Т.В. Изучение химического состава препаратов на основе сырья боярышника // Материалы IX международного симпозиума «Фенольные соединения: фундаментальные и прикладные аспекты», Москва. 2015. С. 578–581.
  36. Dinesh Kumar, Vikrant Arya, Zulfi qar Ali Bhat, Nisar Ahmad Khan, Deo Nandan Prasad. The genus Crataegus: chemical and pharmacological perspectives // Revista Brasileira de Farmacognosia Brazilian Journal of Pharmacognosy. 2012. No. 22(5). P. 1187–1200. URL: http://www.scielo.br/pdf/rbfar/v22n5/aop05712.pdf (дата обра-щения: 24.01.2018).
  37. Jiaqi Wu, Wei Peng, Rongxin Qin, Hong Zhou. Crataegus pinnatifi da: Chemical Constituents, Pharmacology, and Potential Applications // Molecules. 2014. No. 19(2). P. 1685–1712. URL: http://www.mdpi.com/1420-3049/19/2/1685 (дата обращения: 24.01.2018). doi: 10.3390/molecules19021685
  38. Seyed Fazel Nabavi, Solomon Habtemariam, Touqeer Ahmed, Antoni Sureda, Maria Daglia, Eduardo Sobarzo-Sánchez, Seyed Mohammad Nabavi. Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications // Nutrients. 2015. No. 7. P. 7708–7728. URL: https://www.ncbi.nlm.nih.gov/pubmed/26378574 (дата обращения: 24.01.2018). doi: 10.3390/nu7095361
  39. Wu S.J., Li Q.J., Xiao X.F., Li M., Yang X.R., Lv T. The research of chemical constituent and pharmacological effects of Crataegus pinnatifi da // Drug Eval. Res. 2010. Vol. 4. P. 316–319.
  40. Kurkina A.V., Pravdivtseva O.E., Kurkin V.A., Dubishchev A.V. Pharmacological activity of fl avonoid-containing plants. Internationaler medizinischer Kongress // Hannover. 2006, pp. 37–38.
  41. Хишова О.М., Бузук Г.Н. Количественное определение процианидинов плодов боярышника // Хими-ко-фармацевтический журнал. 2006. Т. 40. № 2. С. 20–21.
  42. Куркина А.В. Определение содержания суммы флавоноидов в плодах боярышника // Химико-фармацевтический журнал. 2014. Т. 48. № 12. С. 27–30.
  43. Куркина А.В. Новые подходы к стандартизации цветков боярышника // Химия растительного сырья. 2013. № 2. С. 171–176. doi: 10.14258/jcprm.1302171
  44. Сагарадзе В.А., Бабаева Е.Ю., Каленикова Е.И. Установление подлинности перспективного вида лекарственного сырья – цветков с листьями боярышника // Вопросы биологической, медицинской и фармацевтической химии. 2017. № 2. С. 26–31.
  45. Сагарадзе В.А., Бабаева Е.Ю., Каленикова Е.И. Определение флавоноидов в цветках с листьями боярышника методом ВЭЖХ со спектрофотометрическим детектированием // Химико-фармацевтический журнал. 2017. № 4. С. 30–34.
  46. Hellenbrand N., Sendker J., Lechtenberg M., Petereit F., Hensel A. Isolation and quantification of oligomeric and polymeric procyanidins in leaves and fl owers of Hawthorn (Crataegus spp.). Fitoterapia. 2015. No. 104. P. 14–22. URL: https://www.ncbi.nlm.nih.gov/pubmed/25917901 (дата обращения: 24.01.2018). doi: 10.1016/j.fitote.2015.04.010
  47. Куркин В.А., Морозова Т.В., Правдивцева О.Е. Исследование по разработке стандартизации листьев боярышника кроваво-красного // Химия растительного сырья. 2017. № 3. С. 169–173.
  48. Mudge E.M., Liu Y., Lund J.A., Brown P.N. Single-laboratory validation for the determination of fl avonoids in hawthorn leaves and fi nished products by LC-UV // Planta Med. 2016. No. 82(17). P. 1487–1492. URL: https:// www.ncbi.nlm.nih.gov/pubmed/27776376 (дата обращения: 24.01.2018).
  49. Cheng S., Qiu F., Huang J., He J. Simultaneous determination of vitexin-2”-O-glucoside, vitexin-2”-O-rhamnoside, rutin, and hyperoside in the extract of hawthorn (Crataegus pinnatifi da Bge.) leaves by RP-HPLC with ultraviolet photodiode array detection // Journal of Separation Science. 2007. No. 30(5). P. 717–721.
  50. Zhe Gao, Ya-Nan Jia, Tian-Yuan Cui, Zhe Han, Ai-Xia Qin, Xiao-Hu Kang, Yu-Lei Pan, Tong Cui. Quantifi cation of ten polyphenols in the leaves of Chinese hawthorn (Crataegus pinnatifi da Bge. var. major N.E. Br.) by HPLC // Asian Journal of Chemistry. 2013. Vol. 25. No. 18. P. 10344–10348.

Copyright (c) 2018 Morozova T.V., Kurkin V.A., Pravdivtseva O.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies